Orforglipron Side Effects: What You Need to Know
Orforglipron, a once-daily oral GLP-1 receptor agonist developed by Eli Lilly, is gaining attention as a promising treatment for type…
Tag: Obesity
The Dangerous Duo: How Obesity and Type 2 Diabetes Are Closely Linked
Obesity and type 2 diabetes are often called “twin epidemics” — and for good reason. These two conditions not only…
Morbid Obesity: Understanding the BMI Range and Why It Matters
In today’s world of fast food, sedentary lifestyles, and stress-driven eating habits, obesity has become one of the most widespread…
Ozempic Burnout: The Emotional Cost of Shortcut Weight Loss
In the pursuit of rapid weight loss, medications like Ozempic (semaglutide) have emerged as popular solutions. Originally developed for managing…
BMI Calculator for Women: What It Means, Why It Matters & When It Doesn’t
Understanding your body weight is important, but the number on the scale doesn’t always tell the full story. That’s where…
Obesity as an Emotional Archive
We often speak about obesity in numbers — calories in, calories out. Charts. Metrics. Diet plans. We measure bodies like…
Orforglipron vs Tirzepatide: A New Chapter in Weight Loss and Diabetes Treatment
Orforglipron and tirzepatide, developed by Eli Lilly, are cutting-edge treatments for type 2 diabetes and obesity. While both aim to…